Highlights

• Measure company and market impact of past and future events within the healthcare industry by monitoring regulatory decisions, filings, meetings, and clinical trials for specific pharmaceutical products.
• Capitalize on alerts about changes in a drug life cycle that may affect manufacturing company performance involving patent filings for medication, patent expirations on drugs, current approval stage, and release of new indications. Review detailed footnotes that provide context and relevance of a drug event. Access curated FDA Orange Book patent and exclusivity expiration dates.
• Gain a holistic view of the pharmaceutical market by analyzing the pipeline for top-level indications and classes. Access comprehensive details of the pharmaceutical market for U.S. and European companies (expanding to Canadian and Asia Pacific coverage) by scanning all possible news sources for FDA or EU drug approvals, litigation, high-impact events, newly marketed generics, and newly approved form/dosage. Generate an upcoming event calendar for specific drug products, manufacturers, and partners. Easily link seven indication levels, five class levels, and competing products with a permanent drug identifier.